{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:09:33Z","timestamp":1777349373452,"version":"3.51.4"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T00:00:00Z","timestamp":1721779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Severe aplastic anemia (SAA) is a life-threatening bone marrow failure syndrome whose development can be triggered by environmental, autoimmune, and\/or genetic factors. The latter comprises germ line pathogenic variants in genes that bring about habitually predisposing syndromes as well as immune deficiencies that do so only occasionally. One of these disorders is the autosomal dominant form of chronic mucocutaneous candidiasis (CMC), which is defined by germ line <jats:italic>STAT1<\/jats:italic> gain-of-function (GOF) pathogenic variants. The resultant overexpression and constitutive activation of STAT1 dysregulate the Janus kinase\/signal transducer and activator of transcription 1 (STAT) signaling pathway, which normally organizes the development and proper interaction of different components of the immunologic and hematopoietic system. Although SAA is an extremely rare complication in this disorder, it gained a more widespread interest when it became clear that the underlying causative pathomechanism may, in a similar fashion, also be instrumental in at least some of the idiopathic SAA cases. Based on these premises, we present herein what is the historically most likely first cord blood\u2013transplanted SAA case in a CMC family with a documented <jats:italic>STAT1<\/jats:italic> GOF pathogenic variant. In addition, we recapitulate the characteristics of the six CMC SAA cases that have been reported so far and discuss the significance of <jats:italic>STAT1<\/jats:italic> GOF pathogenic variants and other STAT1 signaling derangements in the context of these specific types of bone marrow failure syndromes. Because a constitutively activated STAT1 signaling, be it driven by <jats:italic>STAT1<\/jats:italic> GOF germ line pathogenic variants or any other pathogenic variant-independent events, is apparently important for initiating and maintaining the SAA disease process, we propose to acknowledge that SAA is one of the definite disease manifestations in <jats:italic>STAT1<\/jats:italic>-mutated CMC cases. For the same reason, we deem it necessary to also incorporate molecular and functional analyses of <jats:italic>STAT1<\/jats:italic> into the diagnostic work-up of SAA cases.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1430938","type":"journal-article","created":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T04:46:51Z","timestamp":1721796411000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Retrospective identification of the first cord blood\u2013transplanted severe aplastic anemia in a STAT1-associated chronic mucocutaneous candidiasis family: case report, review of literature and pathophysiologic background"],"prefix":"10.3389","volume":"15","author":[{"given":"Franz-Martin","family":"Fink","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"H\u00f6pfl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Witsch-Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Kropshofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Heeg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Zschocke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oskar A.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.949435","article-title":"Fanconi anemia and dyskeratosis congenita\/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability","volume":"12","author":"Fiesco-Roa","year":"2022","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006481","article-title":"Inherited bone marrow failure in the pediatric patient","volume":"140","author":"Dokal","year":"2022","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1053\/j.seminhematol.2018.05.016","article-title":"Acquired and germline\u00a0predisposition to bone marrow failure: Diagnostic features and clinical\u00a0implications","volume":"56","author":"Kallen","year":"2019","journal-title":"Semin Hematol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001549","article-title":"Bone marrow failure in fanconi anemia: clinical and genetic spectrum in a cohort of 20 pediatric patients","volume":"41","author":"Kelaidi","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"923247096211056770","DOI":"10.1177\/23247096211056770","article-title":"Novel adenosine deaminase 2 (ADA2) mutations associated with hematological manifestations","volume":"9","author":"Albalawi","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0525-8","article-title":"Deficiency of adenosine deaminase 2 (DADA2): updates on the phenotype, genetics, pathogenesis, and treatment","volume":"38","author":"Meyts","year":"2018","journal-title":"J Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0480-4","article-title":"Hematologic manifestations of deficiency of adenosine deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in DADA2-associated bone marrow failure","volume":"38","author":"Michniacki","year":"2018","journal-title":"J Clin Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-247653","article-title":"A family with cytotoxic T-lymphocyte-associated protein 4 haploinsufficiency presenting with aplastic anaemia","volume":"15","author":"Solhaug","year":"2022","journal-title":"BMJ Case Rep"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.935321","article-title":"Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders","volume":"13","author":"Bleesing","year":"2022","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020009620","article-title":"Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function","volume":"137","author":"Aluri","year":"2021","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010463","article-title":"TLR8 gain of function: a tall surprise","volume":"137","author":"Boisson","year":"2021","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01017-0","article-title":"STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure","author":"Solimando","year":"2023","journal-title":"Clin Exp Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.928213","article-title":"Case report: A STAT1 gain-of-function mutation causes a syndrome of combined immunodeficiency, autoimmunity and pure red cell aplasia","volume":"13","author":"Xie","year":"2022","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.medj.2021.12.003","article-title":"JAK inhibition in a patient with a STAT1 gain-of-function variant reveals STAT1 dysregulation as a common feature of aplastic anemia","volume":"3","author":"Rosenberg","year":"2022","journal-title":"Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1016\/j.jaci.2016.11.022","article-title":"Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation","volume":"139","author":"Weinacht","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1343138","article-title":"Progress in molecular diagnosis and treatment of chronic mucocutaneous candidiasis","volume":"15","author":"Jing","year":"2024","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-319-50842-9_3","article-title":"Genetics of Chronic Mucocutaneous Candidiasis","volume-title":"Immunogenetics of Fungal Diseases","author":"Wang","year":"2017"},{"key":"B19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10875-015-0214-9","article-title":"The extended clinical phenotype of 26 patients with chronic mucocutaneous candidiasis due to gain-of-function mutations in STAT1","volume":"36","author":"Depner","year":"2016","journal-title":"J Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1618300114","article-title":"Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency","volume":"113","author":"Levy","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.71","article-title":"Chronic mucocutaneous candidiasis disease associated with inborn errors of IL-17 immunity","volume":"5","author":"Okada","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679902","article-title":"Heterozygous STAT1 gain-of-function mutations underlie an unexpectedly broad clinical phenotype","volume":"127","author":"Toubiana","year":"2016","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.09.002","article-title":"An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis","volume":"39","author":"Boisson","year":"2013","journal-title":"Immunity"},{"key":"B24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1100102","article-title":"STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis","volume":"365","author":"van de Veerdonk","year":"2011","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlife.2024.03.002","article-title":"Dysregulated STAT1 gain-of-function: Pathogen-free autoimmunity and fungal infection","author":"Guo","year":"2024","journal-title":"hLife"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.654406","article-title":"Clinical relevance of gain- and loss-of-function germline mutations in STAT1: A systematic review","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-715029","article-title":"When the STATs are against you","volume":"127","author":"Hambleton","year":"2016","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.07.020","article-title":"Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations","volume":"142","author":"Forbes","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.01.004","article-title":"Targeted strategies directed at the molecular defect: Toward precision medicine for select primary immunodeficiency disorders","volume":"139","author":"Notarangelo","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw020","article-title":"Ruxolitinib induces interleukin 17 and ameliorates chronic mucocutaneous candidiasis caused by STAT1 gain-of-function mutation","volume":"62","author":"Mossner","year":"2016","journal-title":"Clin Infect Dis"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2014.12.1867","article-title":"Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation","volume":"135","author":"Higgins","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.239731","article-title":"Age- and sex-specific dynamics in 22 hematologic and biochemical analytes from birth to adolescence","volume":"61","author":"Zierk","year":"2015","journal-title":"Clin Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B34","article-title":"Chronic mucocutaneous candidiasis with macrophage dysfunction, a plasma inhibitor, and co-existent aplastic anemia","volume":"85","author":"Twomey","year":"1975","journal-title":"J Lab Clin Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198605000-00006","article-title":"Severe aplastic anemia associated with chronic mucocutaneous candidiasis. Immunologic and hematologic reconstitution after allogeneic bone marrow transplantation","volume":"41","author":"Deeg","year":"1986","journal-title":"Transplantation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","article-title":"Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations","volume":"141","author":"Leiding","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1182\/blood.V95.1.19","article-title":"The Jak-Stat pathway in normal and perturbed hematopoiesis","volume":"95","author":"Ward","year":"2000","journal-title":"Blood"},{"key":"B38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1189\/jlb.5RI0516-237RR","article-title":"STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases","volume":"101","author":"Lorenzini","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41525-021-00196-7","article-title":"STAT1 gain-of-function heterozygous cell models reveal diverse interferon-signature gene transcriptional responses","volume":"6","author":"Scott","year":"2021","journal-title":"NPJ Genom Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.adl2016","article-title":"Interferon-gamma and infectious diseases: Lessons and prospects","volume":"384","author":"Casanova","year":"2024","journal-title":"Science"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13300","article-title":"Human STAT1 gain of function with chronic mucocutaneous candidiasis: A comprehensive review for strengthening the connection between bedside observations and laboratory research","volume":"322","author":"Asano","year":"2024","journal-title":"Immunol Rev"},{"key":"B42","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-023-01620-3","article-title":"The IL-17 family in diseases: from bench to bedside","volume":"8","author":"Huangfu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade7028","article-title":"Dysregulated IFN-gamma signals promote autoimmunity in STAT1 gain-of-function syndrome","volume":"15","author":"Largent","year":"2023","journal-title":"Sci Transl Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500909","article-title":"IL-17-mediated immunity to the opportunistic fungal pathogen candida albicans","volume":"195","author":"Conti","year":"2015","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nri3897","article-title":"Immune defence against Candida fungal infections","volume":"15","author":"Netea","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110958","article-title":"Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis","volume":"208","author":"Liu","year":"2011","journal-title":"J Exp Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2010.10.006","article-title":"Signal transduction pathways and transcriptional regulation in Th17 cell differentiation","volume":"21","author":"Hirahara","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.631329","article-title":"Type I interferonopathies in children: an overview","volume":"9","author":"d'Angelo","year":"2021","journal-title":"Front Pediatr"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.3390\/medicina59122170","article-title":"All roads lead to interferon-gamma: from known to untraveled pathways in acquired aplastic anemia","volume":"59","author":"Serio","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2021.101276","article-title":"Immunologic effects on the haematopoietic stem cell in marrow failure","volume":"34","author":"Patel","year":"2021","journal-title":"Best Pract Res Clin Haematol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s40778-018-0139-3","article-title":"The role of interferon-gamma in hematopoietic stem cell development, homeostasis, and disease","volume":"4","author":"Morales-Mantilla","year":"2018","journal-title":"Curr Stem Cell Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00330","article-title":"Hematopoietic stem cell regulation by type I and II interferons in the pathogenesis of acquired aplastic anemia","volume":"7","author":"Smith","year":"2016","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01433","article-title":"STAT1 gain-of-function mutations cause high total STAT1 levels with normal dephosphorylation","volume":"10","author":"Zimmerman","year":"2019","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-018-0557-0","article-title":"Increased STAT1 amounts correlate with the phospho-STAT1 level in STAT1 gain-of-function defects","volume":"38","author":"Bernasconi","year":"2018","journal-title":"J Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.632997","article-title":"Transcriptional profiling of STAT1 gain-of-function reveals common and mutation-specific fingerprints","volume":"12","author":"Giovannozzi","year":"2021","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41525-018-0063-6","article-title":"Two different STAT1 gain-of-function mutations lead to diverse IFN-gamma-mediated gene expression","volume":"3","author":"Ovadia","year":"2018","journal-title":"NPJ Genom Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"B58","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/jof3040052","article-title":"The role of IL-17 in protection against mucosal candida infections","volume":"3","author":"Mengesha","year":"2017","journal-title":"J Fungi (Basel)"},{"key":"B59","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1126\/science.aay5731","article-title":"Aberrant type 1 immunity drives susceptibility to mucosal fungal infections","volume":"371","author":"Break","year":"2021","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.09.035","article-title":"STAT1 gain-of-function and dominant negative STAT3 mutations impair IL-17 and IL-22 immunity associated with CMC","volume":"138","author":"Hiller","year":"2018","journal-title":"J Invest Dermatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302246","article-title":"IL-27 induces th17 differentiation in the absence of STAT1 signaling","volume":"195","author":"Peters","year":"2015","journal-title":"J Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445344","article-title":"Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC)","volume":"45","author":"Zheng","year":"2015","journal-title":"Eur J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxm139","article-title":"IL-27 inhibits the development of regulatory T cells via STAT3","volume":"20","author":"Huber","year":"2008","journal-title":"Int Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03047","article-title":"IRF and STAT transcription factors - from basic biology to roles in infection, protective immunity, and primary immunodeficiencies","volume":"9","author":"Mogensen","year":"2018","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20161427","article-title":"PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients","volume":"214","author":"Zhang","year":"2017","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.004","article-title":"Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival","volume":"131","author":"Romberg","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"107108647","DOI":"10.1016\/j.intimp.2022.108647","article-title":"An overview of immune checkpoint therapy in autoimmune diseases","volume":"107","author":"Mohammadi","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.854967","article-title":"PD-1\/PD-L1 inhibitors in patients with preexisting autoimmune diseases","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.04.023","article-title":"Treatment options for chronic mucocutaneous candidiasis","author":"van de Veerdonk","year":"2016","journal-title":"J Infect"},{"key":"B71","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10875-018-0575-y","article-title":"Hematopoietic stem cell transplantation in patients with heterozygous STAT1 gain-of-function mutation","volume":"39","author":"Kiykim","year":"2019","journal-title":"J Clin Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.10.018","article-title":"JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: An ESID\/EBMT-IEWP retrospective study","volume":"153","author":"Fischer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-022-01257-x","article-title":"Impact of JAK inhibitors in pediatric patients with STAT1 gain of function (GOF) mutations-10 children and review of the literature","volume":"42","author":"Deya-Martinez","year":"2022","journal-title":"J Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-020-00847-x","article-title":"Human STAT1 gain-of-function heterozygous mutations: chronic mucocutaneous candidiasis and type I interferonopathy","volume":"40","author":"Okada","year":"2020","journal-title":"J Clin Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-020-02860-7","article-title":"Ruxolitinib treatment of a patient with steroid-dependent severe autoimmunity due to STAT1 gain-of-function mutation","volume":"112","author":"Moriya","year":"2020","journal-title":"Int J Hematol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.jaci.2017.08.040","article-title":"Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations","volume":"141","author":"Vargas-Hernandez","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s10875-018-0519-6","article-title":"Utility of ruxolitinib in a child with chronic mucocutaneous candidiasis caused by a novel STAT1 gain-of-function mutation","volume":"38","author":"Bloomfield","year":"2018","journal-title":"J Clin Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0312-3","article-title":"Severe early-onset combined immunodeficiency due to heterozygous gain-of-function mutations in STAT1","volume":"36","author":"Baris","year":"2016","journal-title":"J Clin Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.05.016","article-title":"Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations","volume":"152","author":"Kunvarjee","year":"2023","journal-title":"J Allergy Clin Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1430938\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T04:46:55Z","timestamp":1721796415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1430938\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,24]]},"references-count":79,"alternative-id":["10.3389\/fimmu.2024.1430938"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1430938","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,24]]},"article-number":"1430938"}}